Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT)

被引:64
作者
Ding, Yun [1 ]
O'Keefe, Heather [1 ]
DeLorey, Jennifer L. [2 ]
Israebt, David I. [1 ]
Messer, Jeffrey A. [1 ]
Chiu, Cynthia H. [1 ]
Skinner, Steven R. [1 ]
Matico, Rosalie E. [4 ]
Murray-Thompson, Monique F. [4 ]
Li, Fan [5 ]
Clark, Matthew A.
Cuozzo, John W. [3 ]
Arico-Muendel, Christopher [1 ,3 ]
Morgan, Barry A. [6 ]
机构
[1] ELT Boston, Platform Technol & Sci, GlaxoSmithKline, Waltham, MA 02451 USA
[2] Tedor Pharma Inc, Cumberland, RI 02864 USA
[3] Xchem Inc, Waltham, MA 02453 USA
[4] GlaxoSmithKline, Biol Reagent & Assay Dev, King Of Prussia, PA 19406 USA
[5] Tufts Healthcare Inst, Boston, MA 02111 USA
[6] Ctr Drug Discovery, Baylor Coll Med, Houston, TX 77030 USA
关键词
DNA-encoded library; ADAMTS-4; inhibitors; AGGRECAN DEGRADATION;
D O I
10.1021/acsmedchemlett.5b00138
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aggrecan degrading metalloprotease ADAMTS-4 has been identified as a novel therapeutic target for osteoarthritis. Here, we use DNA-encoded Library Technology (ELT) to identify novel ADAMTS-4 inhibitors from a DNA-encoded triazine library by affinity selection. Structure activity relationship studies based on the selection information led to the identification of potent and highly selective inhibitors. For example, 4-(((4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-6(((4-methylpiperazin-l-yOmethyl)amino)-1,3,5-triazin-2-yl)amino)methyl)-N-ethyl-N-(m-tolyl)benzamide has IC50 of 10 nM against ADAMTS-4, with >1000-fold selectivity over ADAMT-5, MMP-13, TACE, and ADAMTS-13. These inhibitors have no obvious zinc ligand functionality.
引用
收藏
页码:888 / 893
页数:11
相关论文
共 21 条
[1]   ENCODED COMBINATORIAL CHEMISTRY [J].
BRENNER, S ;
LERNER, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5381-5383
[2]   Design, synthesis and selection of DNA-encoded small-molecule libraries [J].
Clark, Matthew A. ;
Acharya, Raksha A. ;
Arico-Muendel, Christopher C. ;
Belyanskaya, Svetlana L. ;
Benjamin, Dennis R. ;
Carlson, Neil R. ;
Centrella, Paolo A. ;
Chiu, Cynthia H. ;
Creaser, Steffen P. ;
Cuozzo, John W. ;
Davie, Christopher P. ;
Ding, Yun ;
Franklin, G. Joseph ;
Franzen, Kurt D. ;
Gefter, Malcolm L. ;
Hale, Steven P. ;
Hansen, Nils J. V. ;
Israel, David I. ;
Jiang, Jinwei ;
Kavarana, Malcolm J. ;
Kelley, Michael S. ;
Kollmann, Christopher S. ;
Li, Fan ;
Lind, Kenneth ;
Mataruse, Sibongile ;
Medeiros, Patricia F. ;
Messer, Jeffrey A. ;
Myers, Paul ;
O'Keefe, Heather ;
Oliff, Matthew C. ;
Rise, Cecil E. ;
Satz, Alexander L. ;
Skinner, Steven R. ;
Svendsen, Jennifer L. ;
Tang, Lujia ;
van Vloten, Kurt ;
Wagner, Richard W. ;
Yao, Gang ;
Zhao, Baoguang ;
Morgan, Barry A. .
NATURE CHEMICAL BIOLOGY, 2009, 5 (09) :647-654
[3]   DNA-encoded chemical libraries of macrocycles [J].
Connors, William H. ;
Hale, Stephen P. ;
Terrett, Nicholas K. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2015, 26 :42-47
[4]   Progress Towards the Identification of New Aggrecanase Inhibitors [J].
De Rienzo, Francesca ;
Saxena, Puneet ;
Filomia, Federico ;
Caselli, Gianfranco ;
Colace, Fabrizio ;
Stasi, Luigi ;
Giordani, Antonio ;
Menziani, Maria Cristina .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (19) :2395-2415
[5]   Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT) [J].
Deng, Hongfeng ;
O'Keefe, Heather ;
Davie, Christopher P. ;
Lind, Kenneth E. ;
Acharya, Raksha A. ;
Franklin, G. Joseph ;
Larkin, Jonathan ;
Matico, Rosalie ;
Neeb, Michael ;
Thompson, Monique M. ;
Lohr, Thomas ;
Gross, Jeffrey W. ;
Centrella, Paolo A. ;
O'Donovan, Gary K. ;
Bedard, Katie L. ;
van Vloten, Kurt ;
Mataruse, Sibongile ;
Skinner, Steven R. ;
Belyanskaya, Svetlana L. ;
Carpenter, Tiffany Y. ;
Shearer, Todd W. ;
Clark, Matthew A. ;
Cuozzo, John W. ;
Arico-Muendel, Christopher C. ;
Morgan, Barry A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7061-7079
[6]   Discovery of Thieno[3,2-4-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3 [J].
Disch, Jeremy S. ;
Evindar, Ghotas ;
Chiu, Cynthia H. ;
Blum, Charles A. ;
Dai, Han ;
Jin, Lei ;
Schuman, Eli ;
Lind, Kenneth E. ;
Belyanskaya, Svetlana L. ;
Deng, Jianghe ;
Coppo, Frank ;
Aquilani, Leah ;
Graybill, Todd L. ;
Cuozzo, John W. ;
Lavu, Siva ;
Mao, Cheney ;
Vlasuk, George P. ;
Perni, Robert B. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (09) :3666-3679
[7]   Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis [J].
Durham, Timothy B. ;
Klimkowski, Valentine J. ;
Rito, Christopher J. ;
Marimuthu, Jothirajah ;
Toth, James L. ;
Liu, Chin ;
Durbin, Jim D. ;
Stout, Stephanie L. ;
Adams, Lisa ;
Swearingen, Craig ;
Lin, Chaohua ;
Chambers, Mark G. ;
Thirunavukkarasu, Kannan ;
Wiley, Michael R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (24) :10476-10485
[8]   Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA [J].
Encinas, Lourdes ;
O'Keefe, Heather ;
Neu, Margarete ;
Remuinan, Modesto J. ;
Patel, Amish M. ;
Guardia, Ana ;
Davie, Christopher P. ;
Perez-Macias, Natalia ;
Yang, Hongfang ;
Convery, Maire A. ;
Messer, Jeff A. ;
Perez-Herran, Esther ;
Centrella, Paolo A. ;
Alvarez-Gomez, Daniel ;
Clark, Matthew A. ;
Huss, Sophie ;
O'Donovan, Gary K. ;
Ortega-Muro, Fatima ;
McDowell, William ;
Castaneda, Pablo ;
Arico-Muendel, Christopher C. ;
Pajk, Stane ;
Rullas, Joaquin ;
Angulo-Barturen, Inigo ;
Alvarez-Ruiz, Emilio ;
Mendoza-Losana, Alfonso ;
Pages, Lluis Ballell ;
Castro-Pichel, Julia ;
Evindar, Ghotas .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) :1276-1288
[9]   Disease-modifying therapies for osteoarthritis - Current status [J].
Fajardo, M ;
Di Cesare, PE .
DRUGS & AGING, 2005, 22 (02) :141-161
[10]   Advances in the development of novel aggrecanase inhibitors [J].
Gilbert, Adam M. ;
Bikker, Jack A. ;
O'Neil, Steven V. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (01) :1-12